1-1 of 1
Authors: Mohammed Manasawala
Journal Article
CTIM-18. NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III TRIAL OF IPILIMIUMAB (IPI) PLUS NIVOLUMAB (NIVO) VS. TEMOZOLOMIDE (TMZ) IN MGMT-UNMETHYLATED (UMGMT) NEWLY DIAGNOSED GLIOBLASTOMA (NGBM)
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v65, https://doi.org/10.1093/neuonc/noad179.0258
Published: 10 November 2023
